The pain experience and its management in cancer patients during hospitalisation (in Namibia)

2000 ◽  
Vol 5 (4) ◽  
pp. 19-26 ◽  
Author(s):  
A SB Van Dyk ◽  
L F Small ◽  
A Zietsman

There is a lack of information on the management of pain in cancer patients in Namibia. For this reason a survey was done to determine the pain experience of cancer patients during hospitalisation and their evaluation of the treatment thereof by nursesOpsommingWeens ‘n gebrek aan inligting oor die hantering van pyn by pasiente met kanker, is 'n opname gedoen na die pyn belewenis van pasiente met karsinoom tydens hospitalisasie. *Please note: This is a reduced version of the abstract. Please refer to PDF for full text.

1989 ◽  
Vol 75 (2) ◽  
pp. 123-131 ◽  
Author(s):  
Natale Cascinelli ◽  
Eva Singletary ◽  
Marco Greco ◽  
Frederick Ames ◽  
Alessandro Testori ◽  
...  

Data on 2170 consecutive patients with breast cancer submitted to curative surgery with or without combined radiotherapy in the period 1968–1972 at the National Cancer Institute of Milan (Italy) and at the University of Texas M.D. Anderson Cancer Center of Houston (Texas, USA) were analyzed to evaluate the prognosis of breast cancer patients after loco-regional treatment only and to verify if different prognostic factors have the same relevance. Forty-four percent of patients were alive without evidence of disease at the end of the follow-up in both centers: 14% of patients treated in Milan died without evidence of breast cancer with an intercurrent disease, whereas the death rate for intercurrent disease was 27 % in Houston. Thirty-seven percent of the patients in Milan and 26% of the patients in Houston died from breast cancer. A considerable percentage of patients (23.4 % in Milano, 38.2% in Houston) had one or more of the required items not specified in the clinical chart. Since the lack of information was considered a possible source of bias, the series were divided into two groups: the first collecting patients with all information available, the second gathering patients with at least one of the required items missing. The latter group was defined « unknown ». Multivariate analysis of survival, carried out by means of Cox's regression model, showed that mortality of these patients for all causes was significantly affected by the following criteria: status of regional nodes (P = 2 × 10−18), unknown (P = 10−9), maximum diameter of primary tumor (P = 7 × 10−10), age of the patients (P = 10−4), site of primary (P = 0.01), and Center (P = 0.04). A significant interaction was found between center and a) age of the patients, b) menopausal status and c) unknown. The relative P values were 6 × 10−7 for age and center, 8 × 10−3 for menopausal and center, 3 × 10−2 for unknown and center. Multivariate analysis of breast cancer mortality was significantly affected by: status of regional nodes (P = 10−18), diameter of primary (P = 5 × 10−14), unknown (P = 2 × 10−13), center (P = 2 × 10−6), site of primary (P = 0.002), and age of the patients (P = 0.03). The same significant interaction as for mortality from all causes was found. It is concluded that comparability of results obtained in different institutions may be dependent on the standardization and availability of patients data. The lack of information may introduce considerable biases in the evaluation of results, as was shown by the relevance of the variable unknown on mortality for all causes and for breast cancer. As regards the number of positive lymph nodes as a criterion to define subgroups of patients with different risks of death, we were unable to identify a definite breaking point. The most widely used categorization of this variable (1–3 positive nodes and 4 or more positive) was not supported by our data.


2008 ◽  
Vol 31 (1) ◽  
pp. 38-46 ◽  
Author(s):  
Eun-Ok Im ◽  
Hyun-Ju Lim ◽  
Maresha Clark ◽  
Wonshik Chee

2016 ◽  
Vol 24 (10) ◽  
pp. 4187-4195 ◽  
Author(s):  
Anna Thit Johnsen ◽  
Morten A. Petersen ◽  
Claire F. Snyder ◽  
Lise Pedersen ◽  
Mogens Groenvold

Author(s):  
Andrik Hermanto ◽  
Tintin Sukartini ◽  
Esti Yunitasari

Background: Anxiety will affect the cancer patient's physiology and decrease the body's immune system, so that intervention is needed to alleviate anxiety. Objective: To find out various non-pharmacalogical therapies to reduce anxiety in cancer patients with chemotherapy. Method: The database used in this study was scopus, proquest and pubmed were limited to the last 5 years of publication from 2016 to 2020, full-text article and in english. The keywords used were "cancer" and "anxiety". This systematic review uses 10 articles that fit the inclusion criteria. Results: nonpharmacological management of cancer patients to reduce anxiety includes music therapy, autogenic training, mindfulness programs, virtual reality, guided imagery and progressive muscle training. Non-pharmacalogical therapy functions to reduce anxiety in cancer patients with chemotherapy and reduce various kinds of side effects such as anaemia, thrombocytopenia, leucopenia, nausea and vomiting, alopecia (hair loss), stomatitis, allergic reactions, neurotoxic, and extravasation (discharge of vesicle or irritant drugs to the patient) subcutaneous tissue resulting in pain, tissue necrosis, and tissue ulceration). Keywords: cancer; anxiety; nonpharmacologic therapy ABSTRAK Latar belakang: Cemas akan mempengaruhi psikologis pasien kanker dan menurunkan sistem imun tubuh, sehingga dibutuhkan intervensi yang dapat meringankan kecemasan. Tujuan: Untuk mengetahui berbagai macam terapi non farmakalogis untuk mengurangi kecemasan pada pasien kanker dengan kemoterapi. Metode: Database yang digunakan dalam studi ini adalah Scopus, Proquest dan Pubmed terbatas untuk publikasi 5 tahun terakhir dari 2016 hingga 2020, full text article dan berbahasa Inggris. Kata kunci yang digunakan adalah “cancer” AND “anxiety”. Systematic review ini menggunakan 10 artikel yang sesuai dengan kriteria inklusi Hasil: Tatalaksana nonfarmakologi pada pasien kanker untuk mengurangi cemas antara lain meliputi terapi musik, latihan autogenik, minfullnes program, virtual reality, guided imagery dan latihan otot progresif. Terapi non farmakalogis berfungsi untuk mengurangi kecemasan pada pasien kanker dengan kemoterapi dan mengurangi berbagai macam efek samping seperti anemia, trombositopenia, leucopenia, mual dan muntah, alopesia (rambut rontok), stomatitis, reaksialergi, neurotoksik, dan ekstravasasi (keluarnya obat vesikan atau iritan ke jaringan subkutan yang berakibat timbulnya rasa nyeri, nekrosis jaringan, dan ulserasi jaringan). Kata kunci: kanker; kecemasan; terapi nonfarmakologi


PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248755
Author(s):  
Eleonora Borelli ◽  
Sarah Bigi ◽  
Leonardo Potenza ◽  
Fabrizio Artioli ◽  
Sonia Eliardo ◽  
...  

Early palliative/supportive care (ePSC) is a medical intervention focused on patient’s needs, that integrates standard oncological treatment, shortly after a diagnosis of advanced/metastatic cancer. ePSC improves the appropriate management of cancer pain. Understanding the semantic and emotional impact of the words used by patients to describe their pain may further improve its assessment in the ePSC setting. Psycholinguistics assumes that the semantic and affective properties of words affect the ease by which they are processed and comprehended. Therefore, in this cross-sectional survey study we collected normative data about the semantic and affective properties of words associated to physical and social pain, in order to investigate how patients with cancer pain on ePSC process them compared to healthy, pain-free individuals. One hundred ninety patients and 124 matched controls rated the Familiarity, Valence, Arousal, Pain-relatedness, Intensity, and Unpleasantness of 94 words expressing physical and social pain. Descriptive and inferential statistics were performed on ratings in order to unveil patients’ semantic and affective representation of pain and compare it with those from controls. Possible effects of variables associated to the illness experience were also tested. Both groups perceived the words conveying social pain as more negative and pain-related than those expressing physical pain, confirming previous evidence of social pain described as worse than physical pain. Patients rated pain words as less negative, less pain-related, and conveying a lower intense and unpleasant pain than controls, suggesting either an adaptation to the pain experience or the role played by ePSC in improving patients’ ability to cope with it. This exploratory study suggests that a chronic pain experience as the one experienced by cancer patients on ePSC affects the semantic and affective representation of pain words.


2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e11078-e11078
Author(s):  
Yin Yin Mon

e11078 Background: Management of breast cancer become individualized nowadays especially in developed countries. Molecular profile of breast cancer is essential to have this management. However, there are still limitations to examine such molecular profile in developing countries like Myanmar. Our aim in this study is to know the number of patients who underwent ER, PR and HER 2 status assessment among breast cancer patients in Myanmar and to analyze types of limitations for the molecular assessment in management of breast cancer. Methods: Total number of 823 breast cancer patients who registered from January 2009 to December 2011 at Medical Oncology Unit of Yangon General Hospital and two private oncology clinics were studied. Results: The age range from 19-80 years and mean age of 44.36 years. Among 823 breast cancer patients, ER, PR and HER 2 status were done in 134 patients (16.28% ) whereas 689 patients( 83.71% ) were not. 604 (87.66%) out of 689 patients who did not undergo profiling were due to financial problem. 60 patients (8.70 %) were found to have lack of information about molecular profiling although they were affordable . 25 patients (3.62 %) lost their tissue due to technological limitation Conclusions: Financial problem is the major limitation to get molecular profile for breast cancer patients in Myanmar. Patients need self expense to do advanced technology examinations in different health care system of our country. In this study we also found out that there was lack of information which leads not to undergo further investigations to some well to do patients. Overall, we believe that molecular technology support with reduced expense will help more patients in future to get better management in breast cancer in Myanmar. Besides, we need to provide update information about molecular testing in breast cancer to not only patients but also health professionals in our country.


2007 ◽  
Vol 16 (7) ◽  
pp. 644-650 ◽  
Author(s):  
Piero Porcelli ◽  
Cinzia Tulipani ◽  
Evaristo Maiello ◽  
Giuseppina Cilenti ◽  
Orlando Todarello

2008 ◽  
Vol 31 (3) ◽  
pp. E17-E23 ◽  
Author(s):  
Eun-Ok Im ◽  
Yi Liu ◽  
Young Hee Kim ◽  
Wonshik Chee

Sign in / Sign up

Export Citation Format

Share Document